Pressrelease – Lund, June 29th, 2026
Preview text: Pressrelease – Lund, June 29th, 2026
Image not available
No image available for this email.
- Subject
- Pressrelease – Lund, June 29th, 2026
- Preview text
- Pressrelease – Lund, June 29th, 2026
- From
- info@
hamletbiopharma.com - Brand
- Hamlet BioPharma
- ESP
- Mailchimp
- Sent
- Mon Jun 29, 2026, 5:14 AM ET
- Size
- 57 KB
- Images
- 8
- Links
- 7, 2 of them buttons
- Subject length
- 36 characters
Against Hamlet BioPharma's usual
Sent in the 5 AM hour, which holds 14% of its emails; 18% arrive in the 4 AM hour. The subject is 36 characters; its average is 45.
Sent just before and after
| Jul 17, 2026 4:45 AM | Uppdatering inför ordinarie teckningsperiod för teckningsoptioner TO5B | |
| Jul 16, 2026 3:11 PM | Pressrelease – Lund, 16 juli 2026 | |
| Jun 29, 2026 8:29 AM | Lund, 29th June, 2026 – Hamlet Biopharma receives European Regulatory Approval | |
| Jun 29, 2026 5:14 AM | Pressrelease – Lund, June 29th, 2026 (this email) | |
| Jun 29, 2026 5:14 AM | Pressrelease – Lund, 29 juni 2026 | |
| Jun 25, 2026 10:29 AM | PRESS RELEASE Lund, June 25th, 2026 | |
| Jun 23, 2026 6:00 AM | Pressrelease – Lund, June 23rd, 2026 |
More from Hamlet BioPharma
All Hamlet BioPharma emailsHamlet BioPharma publicerar årsredovisning 2025/2026
Oct 30, 2026 4:01 AM
PRESS RELEASE Lund, October 28th, 2026
Oct 28, 2026 6:09 AM
